Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular len... SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was incorporated in 2019 and is based in Aliso Viejo, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.335 | -6.675 | 20 | 20.27 | 17.6 | 47982 | 18.82982122 | CS |
| 4 | -7.105 | -27.5708187815 | 25.77 | 26.03 | 17.6 | 48264 | 21.03496381 | CS |
| 12 | -7.705 | -29.2188092529 | 26.37 | 28.2 | 17.6 | 88379 | 24.01573526 | CS |
| 26 | -6.585 | -26.0792079208 | 25.25 | 30.56 | 17.6 | 94422 | 25.21360051 | CS |
| 52 | -6.585 | -26.0792079208 | 25.25 | 30.56 | 17.6 | 94422 | 25.21360051 | CS |
| 156 | -6.585 | -26.0792079208 | 25.25 | 30.56 | 17.6 | 94422 | 25.21360051 | CS |
| 260 | -6.585 | -26.0792079208 | 25.25 | 30.56 | 17.6 | 94422 | 25.21360051 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
